Table of Contents

1. Research Objectives and Assumptions
   • Research Objectives
   • Assumptions
   • Abbreviations
2. Market Overview
   • Report Description
     • Market Definition and Scope
   • Executive Summary
     • Market Snapshot, By Pipeline Phase
     • Market Snapshot, By Application
     • Market Snapshot, By Region
   • Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
   • Market Dynamics
     • Drivers
     • Restraints
     • Market Opportunities
   • Impact Analysis
   • Market Trends
   • Key Developments
   • Disease Type Approval
   • Collaboration/Merge/Acquisition
   • Regulatory Landscape
   • PEST Analysis
   • Porter’s Five Forces Analysis
   • Epidemiology
   • Robust Pipeline Analysis
4. Global Peptide Cancer Vaccine Market, By Pipeline Phase, 2021 – 2033, (USD Billion)
   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Research
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Preclinical
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Phase-I
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Phase-I/II
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Phase-II
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Phase-III
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
5. Global Peptide Cancer Vaccine Market, By Application, 2021 – 2033, (USD Billion)
   • Introduction
     • Market Share Analysis, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, 2022– 2033
     • Segment Trends
   • Colorectal Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Lung Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Pancreatic Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Gastric Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Prostate Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
   • Breast Cancer
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (USD Billion)
6. Global Peptide Cancer Vaccine Market, By Region, 2021 – 2033, (USD Billion)
   • Introduction
     • Market Share Analysis, By Region, 2026 and 2033 (%)
     • Y-o-Y Growth Analysis, For Regions, 2022–2033
     • Regional Trends
   • North America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • U.S.
       • Canada
   • Latin America
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • Brazil
       • Mexico
       • Argentina
       • Rest of Latin America
   • Europe
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • U.K.
       • Germany
       • Italy
       • France
       • Spain
       • Russia
       • Rest of Europe
   • Asia Pacific
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • China
       • India
       • Japan
       • ASEAN
       • Australia
       • South Korea
       • Rest of Asia Pacific
   • Middle East
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (USD Billion)
       • GCC
       • Israel
       • Rest of Middle East
   • Africa
     • Introduction
     • Market Size and Forecast, and Y-o-Y Growth, By Pipeline Phase, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Billion)
     • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (USD Billion)
       • North Africa
       • Central Africa
       • South Africa
7. Competitive Landscape
   • Heat Map Analysis
   • Market Share Analysis
   • Company Profile
     • Marker Therapeutics, Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Agenus
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Merck
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • BrightPath Biotherapeutics
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Boston Biomedical
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • VAXON Biotech
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Nouscom
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Lytix Biopharma
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • ISA Pharmaceuticals
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Generex Biotechnology
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • OncoTherapy Science
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Enzo Life Science
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Immatics Biotechnologies
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • SELLAS Life Sciences Group
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Ultimovacs
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Celldex therapeutics
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
     • Immunomic Therapeutics, Inc.
       • Company Highlights
       • Product Portfolio
       • Financial Performance
       • Recent Highlights
       • Market Strategies
   • Analyst Views
8. Section
   • References
   • Research Methodology
   • About Us